Saturday, May 23, 2015 11:30:07 PM
If you do not think they are interested, I just do not know what else I can say to connect the dots. I just wonder why Dr. Joe Cunning is on the KBLB Advisory Board. Was he placed there by DD, or did Kim invite him to join the board. It is probably the latter reason, but then Kim has his reasons for asking him to join the board. No matter which scenario it is, Dr. Cunning's connection to KBLB is directly related to DD, and no one will ever change my mind about that. He is there for a reason.
If DD does not move soon, then other companies will be stepping forward. I still say we will be bought out by the end of next year at the absolute latest. However, I am beginning to believe it could very well be this year and much sooner than any of us, including me, can imagine.
Who knows, it could be why Kim has been so quiet, aside from the S-1A. There has been an eerie silence around KBLB and WM, and the hiring of a law firm specializing in mergers and acquisitions is a bit coincidental.
Of course, some just will not understand how these dots are all interrelated, but I see it clearly. There are just too many coincidences for all of it to be just luck. IMHO, it is a fact, and it is coming.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM